Page last updated: 2024-10-30

metaproterenol and Intracranial Arteriosclerosis

metaproterenol has been researched along with Intracranial Arteriosclerosis in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tobiasch, V1
Mansour, O1
Schwerdtfeger, B1

Other Studies

1 other study available for metaproterenol and Intracranial Arteriosclerosis

ArticleYear
[Orthostatic vertigo].
    Die Medizinische Welt, 1972, Sep-09, Volume: 23, Issue:37

    Topics: Dysautonomia, Familial; Ergot Alkaloids; Female; Humans; Intracranial Arteriosclerosis; Male; Metapr

1972